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Abstract 
Purpose: Despite a growing literature on the benefits of gratitude for adjustment to chronic 
illness, little is known about gratitude in medical populations compared to healthy 
populations, or the degree to which potential deficits in gratitude might impact quality of life. 
The purpose of the present study was to: 1) examine levels of gratitude and quality of life in 
fibromyalgia patients and healthy controls, and 2) consider the role of gratitude in explaining 
quality of life differences between fibromyalgia patients and healthy controls. 
Methods: Participants were 173 fibromyalgia patients and 81 healthy controls. All 
participants completed measures of gratitude, quality of life, and socio-demographics. 
Results: Although gratitude was positively associated with quality of life, levels of gratitude 
and quality of life were lower in the fibromyalgia sample relative to the healthy controls. This 
difference in gratitude partially mediated differences in quality of life between the two groups 
after controlling for sociodemographic variables.  
Conclusions: Our findings suggest that gratitude is a valuable positive psychological trait for 
quality of life in people with fibromyalgia. Interventions to improve gratitude in this patient 
population may also bring enhancement in quality of life. 
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Introduction 
Characterized by muscle pain, fatigue, and tender points [1], fibromyalgia is a chronic 
pain syndrome that can significantly compromise daily functioning and quality of life [2,3]. 
Sleeping difficulties and cognitive problems, including memory issues (i.e., “fibro fog”), are 
common in up to 70% of patients [4]. These factors can exacerbate pain and problems with 
daily functioning [5], key components of health-related quality of life in fibromyalgia 
syndrome (FMS). Together, the cognitive and physical symptoms of FMS can detrimentally 
impact psychological and physical well-being [6]. The toll on mental health is evidenced by 
the high rates of anxiety and depression in people with FMS compared to the general 
population [7,8], which in turn can further compromise quality of life [9]. 
From the lens of positive clinical psychology [10], certain qualities and traits can 
provide resilience to the challenges of living with chronic conditions such as FMS, and thus 
ameliorate the impact of FMS on quality of life. For example, positive affect has been 
identified as an asset for managing fibromyalgia [11], and trait hope, which is characterized 
by high levels of positive affect, is linked to lower levels of fatigue among fibromyalgia 
patients [12]. A growing evidence base indicates that gratitude, an orientation towards 
noticing and appreciating the positive in life [13], may be particularly beneficial for 
improving quality of life in clinical populations, including those with chronic health 
conditions. As a trait construct, gratitude is associated with lower levels of depression in 
those with heart failure and breast cancer [14,15], and longitudinally predicts lower 
depression in individuals with inflammatory bowel disease and arthritis [16]. Gratitude is also 
associated with enhanced quality of life in arthritis, chronic obstructive pulmonary disease, 
and diabetes [17], and better self-rated health, in people with inflammatory bowel disease and 
arthritis [16]. Yet to date, gratitude has not been specifically examined with respect to quality 
of life in FMS. 
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There are several reasons to expect that gratitude may be linked to better health-
related quality of life in FMS. In healthy populations, gratitude is associated with better sleep 
quality via better pre-sleep cognitions [18], and lower depression both cross-sectionally [19], 
and longitudinally [20,13]. Gratitude is also associated with well-being in non-clinical 
populations after controlling for other known predictors such as socio-demographic factors 
and higher-order personality traits [21], and is linked to adaptive coping [22].  
Despite the value of gratitude for enhancing well-being, little is known about the 
relative levels of gratitude among those living with a chronic health condition compared to 
healthy populations, or the degree to which deficits in gratitude might impact well-being for 
those with FMS. Ostensibly, living with FMS can make focusing on and appreciating the 
positive more difficult, as FMS can have a widespread negative impact on personal 
relationships, career, and mental health [3], in addition to impeding daily functioning [2]. 
Among the eight diverse facets of gratitude identified by Wood and colleagues (2010), 
appreciation of one’s social relationships and the support they provide, and positive social 
comparisons, are two key social dimensions of gratitude that may be difficult for people with 
FMS to experience. Both quality and quantity of social support are important for improving 
disease self-management and quality of life in people with FMS [23], yet social support is 
often lacking for individuals with FMS [3]. To the extent that social networks do not include 
peers with FMS or other chronic illnesses, opportunities for positive social comparisons may 
be scarcer for individuals with FMS than for those not living with this chronic condition, and 
may limit their capacity to make growth-oriented upward social comparisons or symptom 
minimising downward social comparisons [24]. Importantly, for gratitude to be considered a 
more enduring life-orientation or trait, each of the eight facets of gratitude would need to be 
experienced frequently, intensely, and easily [25,19]. Given this, and the impact of FMS on 
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daily and social functioning, it may be difficult for people with FMS to have a sustained 
grateful approach to life when managing the challenges of their condition.  
The Present Study 
In the current study we addressed an important and understudied question regarding 
the role of gratitude in adjustment to chronic illness, namely the extent to which gratitude 
might be a limited, but nonetheless valuable, positive psychological trait for health-related 
quality of life in people with FMS. To test this we examined the levels of trait gratitude in 
people with FMS relative to a healthy control group, and further tested the associations of 
gratitude to a composite measure of health-related quality of life in both samples. Because 
current evidence indicates that gratitude is a core resiliency factor for both healthy and 
chronically ill populations, we expected that gratitude would be linked to improved mental 
health and quality of life in both the FMS and the control samples. However, given the 
challenges of living with FMS, we also hypothesized that individuals with FMS would report 
lower overall quality of life and lower levels of trait gratitude compared to a healthy control 
group. We further hypothesized that the deficits in quality of life in those with FMS would be 
explained by their relatively lower levels of gratitude.  
Methods 
Participants & Procedures 
FMS patients (n = 171) and healthy controls (n = 81) participated in the study. Table 1 
provides descriptive statistics for each group and tests of group differences for socio-
demographic variables. Patients and controls did not differ in terms of sex or marital status. 
Patients were about 12 years older than controls and more likely to have 9-11 years of 
education as compared to controls who were more likely to have 12 or more years of 
education.  
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In total 320 questionnaire sets were sent out to several fibromyalgia self-help groups 
which were recruited with the support of the German Fibromyalgia Patient Association. The 
group leaders were contacted by an author (MO) and were then sent the patient materials 
including the questionnaires, an information letter regarding the study objectives, and a 
consent form. Group leaders were asked to distribute the materials and to collect and return 
them when completed. Healthy controls were a German convenience sample of volunteers 
without fibromyalgia that completed the questionnaire set. The questionnaires were delivered 
to student assistants by one of the authors (NK) and students then delivered them to people 
they knew (e.g., parents, parents’ friends, and other individuals 40 to 70 years of age).  
Measures 
 The Gratitude Questionnaire-6. The Gratitude Questionnaire-6 is a brief (6-item) 
assessment of the disposition of gratefulness [25]. It was developed for use with a wide 
variety of respondents and has been used with college students, the general population, and 
medical patients [16,25]. The gratitude questionnaire has shown evidence of acceptable 
reliability and validity [25]. Responses are provided on a Likert scale ranging from 1 
(strongly disagree) to 7 (strongly agree). The total score can range from 6 to 42 and higher 
scores indicate higher gratitude. In the present study, coefficient alpha for patients and 
controls was .79 and .69, respectively. 
 Hospital Anxiety and Depression Scale. The Hospital Anxiety and Depression Scale 
is a brief (14 item) self-report questionnaire measuring symptoms of anxiety and depression 
[26]. It was developed for use in general medical out-patient clinics but is now widely used in 
clinical practice and research. The Hospital Anxiety and Depression Scale has good 
reliability and construct validity [27]. Responses are based on the relative frequency of 
symptoms over the past week, using a four point Likert scale ranging from 0 (not at all) to 3 
(very often). The total score for each of the depression and anxiety scales can range from 0 to 
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21 and higher scores indicate higher depression and anxiety. In the present study, coefficient 
alpha for anxiety for patients and controls was .86 and .76, respectively. Coefficient alpha for 
depression for patients and controls in the present study was .82 and .81, respectively. 
Quality of Life Scale. The Quality of Life Scale is a 16-item questionnaire designed 
specifically for use in chronic disease patients including patients with fibromyalgia [28]. 
Items assess various aspects of quality of life such as physical and material well-being, 
relationships with other people, social, community, and civic activities, personal development 
and fulfillment, recreation, and independence. Satisfactory construct validity has been shown 
for the German version in a sample of fibromyalgia patients [29]. The items are scaled from 1 
to 7 and aggregated into a sum score where a higher score indicates higher quality of life 
(possible sum score range 16-112). In the present study, coefficient alpha for patients and 
controls was .91 and .91, respectively. 
 Short Form 12. The Short Form 12 is a multidimensional general measurement 
instrument assessing health-related quality of life. It has become widely used in clinical trials 
and as a standard outcome assessment instrument because of its brevity and psychometric 
performance [30]. Like the full version of the Short Form (i.e., SF-36), the Short Form 12 
contains items that assess function in eight health domains including: physical functioning, 
role-physical, bodily pain, general health, vitality, social functioning, role-emotional, and 
mental health. However, because only one or two items could be devoted to each of the 
domains in the Short Form 12, domain subscales are typically not computed. Instead, the 
Short Form 12 consists of mental and physical health composite scores. Scores can range 
from 0 to 100 with higher scores indicating better health-related quality of life. Acceptable 
estimates of internal consistency have been shown for both mental (coefficient alpha = .82) 
and physical (coefficient alpha = .88) health composite scores [31]. Mental and physical 
health composite scores have shown acceptable two-week test-retest reliability coefficients of 
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.76 - .89 [32,33]. Internal consistency of the mental (coefficient alpha = .84) and physical 
(coefficient alpha = .91) health composite scores in the present study was acceptable. 
Because of the present focus on mental health-related quality of life, only the mental health 
composite score was used in this study. 
Socio-demographics. Age and sex were assessed, as were educational level (i.e., 9 or 
less years, 10-11 years, 12 or more years, advanced) and marital status (i.e., married versus 
other).  
Analyses 
 Descriptive statistics (means and standard deviations) were computed along with 
bivariate correlations. Next, a multiple group confirmatory factor analysis model was fit to 
the data to evaluate the latent quality of life variable and ensure measurement invariance 
across FMS patients and healthy controls. Several different levels of measurement invariance 
can be considered [34]. Testing for configural invariance evaluates if the same factor model 
(i.e., number of factors and indicators) fits equally well in both groups. Testing for metric 
invariance adds the requirement that the factor loadings must be equal for both groups. 
Testing for scalar invariance involves evaluating factor variance/covariance invariance tests 
determining if the variances and covariances of the latent factors are equal for both groups. 
Last, testing for strict factorial invariance adds the final equality constraint consisting of the 
requirement that all item residuals are invariant across both groups. Multiple group 
confirmatory factor analysis models are complex and include numerous parameters, 
consequently RMSEA is the preferred fit index as it possesses known distributional 
properties and remains unaffected by model complexity or sample size [35,36]506($
.08 is considered acceptable fit [35]. However, strict RMSEA cutoffs do not exist and values 
of up to .10 can be considered acceptable [37]. Multiple group confirmatory factor analysis 
loadings are usually provided in unstandardized units. This prevents confusion in interpreting 
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standardized loadings that may differ across groups due to different variances in each group 
[38]. Nevertheless, both unstandardized and standardized loadings are provided for 
interpretation.  
Tests of study hypotheses involved a structural equation model that examined the 
hypothesis that FMS patients and controls would differ on quality of life and that some 
portion of this difference could be explained by gratitude levels. The structural model 
included a direct effect representing the difference between FMS patients and healthy 
controls on quality of life, as well as, on gratitude. The model also included the direct effect 
of gratitude on quality of life. An indirect effect was included in the model that represented 
the extent to which FMS patient and healthy control differences in quality of life were 
explained by group differences in gratitude. Testing the significance of the indirect effect in a 
structural equation model is the recommended and most direct method for understanding if a 
mediating variable conveys the effects of a predictor to an outcome [39,40]. There are a 
number of advantages to testing for mediation by examination of the indirect effect in 
structural equation modeling [41]. Some of the advantages include the ability to include latent 
variables, simultaneous, as opposed to sequential, estimation of model effects, and modeling 
error terms in the equation. Structural equation models also allow for testing nested models 
that can help evaluate if direct or indirect effects could be eliminated, making the model more 
parsimonious [42]. The influence of socio-demographic variables on all other variables in the 
model was controlled. We assessed fit of the structural models using the ratio of chi-square 
value to degrees of freedom (CMIN/df), Comparative Fit Index (CFI), Tucker-Lewis-Index 
(TLI), and root mean square error of approximation (RMSEA) [38]. In order to assess model 
fit, conventional cut-off criteria (good fit: CMINI/df < 2; CFI>.97; TLI:>.97, RMSEA<.05; 
acceptable fit: CMINI/df < 3; CFI>.95; TLI:>.95, RMSEA<.10) were employed [43]. 
Statistical significance tests were considered at the p < .05 level. 
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Results 
 Descriptive statistics and tests of group differences are shown in Table 2. Being an 
FMS patient was associated with lower gratitude, quality of life and mental health-related 
quality of life, and higher anxiety and depression in comparison to a healthy control group. 
Compared to other FMS patient cohorts’ levels of quality of life (M = 72), mental health-
related quality of life (M = 42), anxiety (M = 11), and depression (M = 8) [29,44-47], FMS 
patients in the present study showed slightly lower quality of life (M = 66) and mental health-
related quality of life (M = 35), equal levels of anxiety (M = 11), and slightly higher 
depression (M = 10). Descriptive statistics and bivariate correlations for the total sample are 
shown in Table 3. Gratitude was correlated with less anxiety and depression and more quality 
of life and mental health-related quality of life. Education was related to more gratitude, 
quality of life, and mental health-related quality of life and less anxiety and depression. Age 
was related to more anxiety and depression and less mental health-related quality of life. 
Participant sex and marital status were not statistically related to any variable.  
 Multiple group confirmatory factor analysis revealed evidence for invariance of the 
quality of life construct across FMS patients and healthy controls. Configural, metric, scalar, 
and strict invariance models all fit the data acceptably, RMSEAs = .00 - .07. Under the 
constraints of the strict invariance model, unstandardized factor loadings ranged from .99 - 
3.67 and standardized factor loadings ranged from .66 - .86. All loadings were statistically 
significant at the p < .001 level. Residuals for anxiety and quality of life were allowed to 
covary in all models. 
 The structural model (see Figure 1) showed that FMS patients had lower levels of 
quality of life than healthy controls (Beta = -.58, p < .001) and lower levels of gratitude (Beta 
= -.36, p < .001). Gratitude had the expected positive association with quality of life (Beta = 
.29, p < .001). The difference between FMS patients and healthy controls in quality of life 
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was partially explained through gratitude (Indirect Beta = -.10, p < .01). The structural model 
showed good ILWȤ2 = 22.50, p = .26, Ȥ2 / df = 1.18, CFI = 1.00, TLI = .99, RMSEA = .03. To 
examine if the mediating role of gratitude in quality of life differences between FMS patients 
and healthy controls was partial or complete, we examined a trimmed model with the direct 
effect between group and quality of life omitted. This model resulted in a statistically poorer 
fit, 'Ȥ2 = 65.27, p < .001. Consequently, we retained the partial mediation model that 
included both the direct and indirect effects. 
Discussion 
 The current study is, to our knowledge, the first to examine the role of trait gratitude 
as a core resiliency factor for people with FMS, and to do so in comparison to a healthy 
control group. FMS patients exhibited lower quality of life and mental health-related quality 
of life and higher anxiety and depression scores compared to healthy controls. The present 
group of FMS patients showed slightly lower quality of life and mental health-related quality 
of life, equal anxiety, and slightly higher depression in comparison to other FMS cohorts 
[29,44-47]. This points to a high burden of disease consequences on overall quality of life in 
our sample of FMS patients. 
Consistent with our hypotheses, gratitude was associated with better quality of life. 
Although those with FMS reported lower average levels of quality of life and trait gratitude 
relative to controls, gratitude was positively linked to a composite index of quality of life. 
Importantly, differences in gratitude levels partially explained the differences in quality of 
life between the two groups, even after accounting for important sociodemographic variables. 
Together, these findings support our proposition that living with FMS presents a challenging 
context that can limit opportunities to express gratitude frequently, intensely, and easily, and 
thus as a trait [19,25], which in turn can have implications for quality of life.  
Despite a growing recognition of the value of gratitude for improving well-being and 
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quality of life for those with chronic illness [15,14,17,16], it is important to acknowledge that 
the challenges of living with a chronic illness nonetheless creates a context in which finding 
people and circumstances to be grateful for on a regular basis may be very limited. Pain, 
fatigue, functional losses, and psychosocial challenges, are issues common to many chronic 
illnesses that can compromise quality of life [48-50], as well as potentially limit how often 
gratitude may be expressed. Erosion of social support is common among people with chronic 
illness [51], and could lead to less grateful responses to the support provided, especially if the 
amount of social support received is viewed as being relatively less than the support 
previously received [52]. Additionally, the extra effort required to maintain a grateful 
orientation in the context of living with a chronic illness may be beyond the resources 
available to the individual. For example, there is evidence that the well-known link between 
pain and poor executive functioning is exacerbated among individuals living with chronic 
pain who try to maintain a positive mood [53], suggesting that there may be limited cognitive 
resources to draw upon when trying to manage a painful chronic health condition. The 
cognitive deficits and “fibro fog” common to FMS are additional reasons why maintaining a 
grateful disposition may be particularly difficult for this patient group. 
From a positive clinical psychology perspective [10], acknowledging when and under 
what circumstances positive traits such as gratitude may be compromised is important for 
reducing the symptoms and development of clinical disorders such as anxiety and depression. 
Rather than focusing only on the benefits of gratitude for adjustment in chronic illness 
populations, future research should also examine potential deficits in gratitude relative to 
healthy populations, as was done in the current study. Such an approach would permit a more 
accurate understanding of the factors that may limit having a grateful orientation.  
Importantly, evidence indicates that gratitude is a quality that can be cultivated with 
relatively simple interventions such as gratitude diaries and lists, which over time can 
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contribute to a more grateful disposition [19]. Indeed, there is evidence that the positive 
effects of gratitude interventions can persist for up to six months [19]. Although a growing 
body of evidence has demonstrated the efficacy of gratitude interventions for increasing the 
expression of gratitude and improving well-being in non-medical populations [19,54], 
research on such interventions in medical populations is scant. At least one study has found 
that gratitude interventions may be equally valuable for chronic illness populations, noting 
that breast cancer patients who received a 6-week online gratitude intervention had 
significant reductions in death-related fear of recurrence compared to a control group [55]. To 
the extent that gratitude can be bolstered to be expressed on a more regular basis via 
interventions, our findings suggest that such interventions have the potential to maximise 
quality of life related outcomes in chronic illness populations. Nonetheless, understanding the 
conditions that may restrict the full expression and experience of gratitude may be necessary 
to optimise the value of these interventions for medical populations.  
Limitations 
Studies of this type come with some limitations worth considering. First, this was a 
cross-sectional study and causal direction cannot be inferred. Nevertheless, it remains useful 
to know that patient-control differences in quality of life are, in some part, accounted for by 
differences in gratitude as impaired quality of life is a common outcome of concern in 
chronic illness and convenient targets of intervention to boost it are not always easily 
identifiable. Gratitude appears to be one such point of intervention. Second, this was a 
convenience sample of patients recruited from a patient self-help group in only one region of 
the world. Broader, more representative samples of patients could have advantages. Third, all 
measures were self-reports and response bias (i.e., faking good or bad) may have affected the 
data. Finally, although we controlled for socio-demographic confounds, other confounding 
variables could be at play. Gratitude may be serving as a proxy for several other positive 
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psychological traits such as optimism, hope, or general positive affect.  
Conclusion 
 Our findings show that gratitude and quality of life are lower in FMS patients as 
compared to healthy controls and that lower gratitude levels explain part of the differences 
between patients and controls in quality of life. FMS patients have long been known to suffer 
decrements in key areas of functioning that contribute to losses in quality of life [e.g., 4], and 
yet few treatment approaches offer sufficient means to regain functional losses and improve 
quality of life. Developing personal resiliency and adopting positive coping styles offer ways 
of adjusting to chronic illnesses such as FMS. Gratitude may serve both purposes, 
functioning to contribute to the development of resilient personal character while also 
offering an approach to coping that is likely to bring quality of life benefits.  
Although the cross-sectional design of this study does not allow for conclusions about 
the causal sequencing of these variables, future studies could illuminate if attempts to 
enhance a grateful disposition can lead to quality of life enhancements and if re-orienting 
coping from a focus on managing the negative to appreciating the positive in life can do 
likewise. The present study and future studies can contribute to a growing body of literature 
demonstrating the importance of gratitude for quality of life and well-being in individuals 
living with a chronic illness [16,14,15]. Overall, research of this kind highlights the 
importance of considering person-situation interactions when assessing how enduring 
positive personal traits such as gratitude may or may not be associated with important 
outcomes such as quality of life in the context of chronic illness.  
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Table 1. 
Socio-Demographic Descriptive Statistics for Fibromyalgia Patients and Controls 
 Patients Controls F Ș2 Ȥ2 r 
Age in years1 58 (8.8) 47 (14.2) 57.76*** .19   
Sex (female/male)2 
  Female 
  Male 
 
161 (95) 
9 (5) 
 
76 (94) 
5 (6) 
  .08 -.02 
Marital status2 
  Married/with partner 
  Single/widowed/divorced  
 
130 (76) 
40 (24) 
 
59 (76) 
19 (24) 
  .02 -.01 
Education (years)2 
  9 or less 
  10 or 11 
  12 or more 
  Advanced 
 
74 (44) 
65 (39) 
16 (10) 
12 (7) 
 
7 (9) 
23 (29) 
44 (56) 
5 (6) 
  68.76*** .41 
1M (SD), F test; 2n (% within 
column), Ȥ2 test 
*** p < .001 
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Table 2.  
Average Levels of Main Study Variables for Fibromyalgia Patients and Controls 
 Patients Controls  
Variable M SD M SD t 
Gratitude 30.45 6.13 35.87 4.10 -6.25*** 
Anxiety 10.93 4.46 5.45 3.15 8.63*** 
Depression 9.51 3.99 2.92 2.95 11.50*** 
Quality of Life 65.99 16.54 86.94 15.77 -8.30*** 
Mental Health-Related 
Quality of Life 
35.36 9.28 49.96 9.22 -10.18*** 
*** p < .001 
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Table 3 
Descriptive Statistics and Bivariate Correlations for all Study Variables 
 M SD 1  2  3  4  5  6  7  8  9 
1. FMS Patients  
    (Healthy Control = referent) 
.70 .46                  
2. Gratitude 32.09 6.10 -.41 ***              
3. Anxiety 9.23 4.83 .52 *** -.39 ***             
4. Depression 7.47 4.80 .63 *** -.50 *** .77 ***           
5. Quality of Life 72.39 18.88 -.51 *** .47 *** -.58 *** -.75 ***         
6. Mental Health-Related Quality of Life 39.82 11.40 -.59 *** .40 *** -.68 *** -.74 *** .63 ***       
7. Age 54.36 11.70 .42 *** -.13 .14 * .20 ** -.10 -.15 *      
8. Sex .94 .23 -.08 -.04 .00 .02 -.04 .08 -.08    
9. Married (other = referent) .76 .43 -.04 .00 .08 .06 .04 -.03 .04 -.07   
10. Education 2.04 .93 -.43 *** .34 *** -.31 *** -.36 *** .24 *** .26 *** -.22 *** -.06  -.03 
* p < .05, ** p < .01, *** p < .001                    
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Figure 1. Structural model for the differences between FMS patients and healthy controls in 
quality of life with differences in gratitude as a mediating variable. All coefficients are 
significant at p < .001. Residual terms and age, sex, marital status, and education control 
variables not shown. With the exception of a positive association between education and 
gratitude (Beta = .20, p < .01), no other control variables had significant associations with 
any other variable. 
